SEC Form 4 · accession 0001654954-19-001388
Pharma-Bio Serv, Inc. · PBSV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pedro J Lasanta
Officer — Chief Financial Officer
Period of report
Feb 7, 2019
Accepted (ET)
Feb 12, 2019 · 9:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001304161
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 7, 2019 | M | 41,625 | $0.86 | A | 125,953 | D | |
| Common StockF1 | Feb 7, 2019 | F | 31,401 | $1.14 | D | 94,552 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $0.86 | Feb 7, 2019 | M | 41,625 | D | — | Dec 17, 2020 | Common Stock | 41,625 | 0 | D |
Explanation of responses
- F1Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
- F2The options vested as follows: 33.3% on December 17, 2016, 66.7% on December 17, 2017 and 100% on December 17, 2018.